Trial Profile
A Randomized Control Trial of Intracoronary Reopro to Improve Coronary Microvascular Function
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2014
Price :
$35
*
At a glance
- Drugs Abciximab (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 27 Jun 2014 New trial record